Literature DB >> 9822215

Roles of the matrix metalloproteinases in mammary gland development and cancer.

C Benaud1, R B Dickson, E W Thompson.   

Abstract

Tissue remodeling is a key process involved in normal development, wound healing, bone remodeling, and embryonic implantation, as well as pathological conditions such as tumor invasion and metastasis, and angiogenesis. The degradation of the extracellular matrix that is associated with those processes is mediated by a number of families of extracellular proteinases. These families include the serine proteinases, such as the plasminogen-urokinase plasminogen activator system and leukocyte elastases, the cysteine proteinases, like cathepsin D and L, and the zinc-dependent matrix metalloproteinases (MMPs) [1]. Accumulating evidence has highlighted the central role of MMP-driven extracellular matrix remodeling in mammary gland development and breast cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822215     DOI: 10.1023/a:1006061115909

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  25 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 2.  Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland.

Authors:  Shannon L Kelleher; Nicholas H McCormick; Vanessa Velasquez; Veronica Lopez
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

Review 3.  Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years.

Authors:  Attiqa N Mirza; Nadeem Q Mirza; Georges Vlastos; S Eva Singletary
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

Review 4.  Role of corneal collagen fibrils in corneal disorders and related pathological conditions.

Authors:  Hong-Yan Zhou; Yan Cao; Jie Wu; Wen-Song Zhang
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

5.  Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.

Authors:  P Elumalai; A Brindha Mercy; R Arunkamar; G Sharmila; F A Bhat; S Balakrishnan; P Raja Singh; J Arunakaran
Journal:  Cell Prolif       Date:  2014-12       Impact factor: 6.831

Review 6.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors:  Roopali Roy; Jiang Yang; Marsha A Moses
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

7.  Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells.

Authors:  Luis Castro-Sanchez; Adriana Soto-Guzman; Margarita Guaderrama-Diaz; Pedro Cortes-Reynosa; Eduardo Perez Salazar
Journal:  Clin Exp Metastasis       Date:  2011-04-02       Impact factor: 5.150

Review 8.  Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland.

Authors:  Carmen Clapp; Stéphanie Thebault; Gonzalo Martínez de la Escalera
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

9.  Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology.

Authors:  Daniel E Abbott; Naira V Margaryan; Jacqueline S Jeruss; Seema Khan; Virginia Kaklamani; David J Winchester; Nora Hansen; Alfred Rademaker; Zhila Khalkhali-Ellis; Mary J C Hendrix
Journal:  Cancer Biol Ther       Date:  2010-01-15       Impact factor: 4.742

Review 10.  Deciphering the molecular basis of breast cancer metastasis with mouse models.

Authors:  Ann E Vernon; Suzanne J Bakewell; Lewis A Chodosh
Journal:  Rev Endocr Metab Disord       Date:  2007-09       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.